GLOBAL AI POWERED CANCER DIAGNOSTICS MARKET

 

INTRODUCTION

 

AI algorithms that can identify ever-smaller lung tumours have been developed in response to the requirement for early diagnosis. Because of the limitations of human eyesight, radiologists are prone to overlooking small cancerous tumours. For example, up to 35% of lung nodules are overlooked during the first examination.

 

 

AI technology can help on both counts by taking part of the load off of overworked professionals and finding lung spots that aren’t evident to the human eye. Computer-assisted diagnostic technologies are already used by radiologists to help them detect malignant tumours. 

 

GLOBAL AI POWERED CANCER DIAGNOSTICS MARKET DEVELOPMENTS AND INNOVATIONS

 

S No	Overview of Development	Development Detailing	Region of Development	Possible Future Outcomes
1	Siemens signed an agreement with Geisinger, a healthcare provider	Access to diagnostic imaging equipment and artificial intelligence applications was the focus of the deal.	Global	This would enhance better Technological Controls
2	Aidoc teamed up with LucidHealth, a physician-owned and led radiology company	The goal of this partnership was for the latter firm to deploy an AI-powered diagnostic tool developed by the former to assist prioritise and speed treatment for patients with urgent, life-threatening diseases.	Global	This would enhance better Technological Controls
3	Zebra Medical Vision announced its collaboration with Johnson & Johnson’s DePuy Synthes.	The goal of the partnership was to provide Cloud-based AI solutions to the orthopaedic and bone health industries together.	Global	This would enhance better Technological Controls
4	AI and machine learning could improve cancer diagnosis through biomarker discovery	These technologies are now being used to tackle the problems of cancer biomarker identification, where the analysis of massive volumes of imaging and molecular data exceeds the capabilities of classic statistical analyses and tools.	Global	This would enhance better Technological Controls
5	Artificial Intelligence System Improves Breast Cancer Detection	Scientists from NYU and NYUAD have built a revolutionary artificial intelligence (AI) system that reaches radiologist-level reliability, according to a recent study.	Global	This would enhance better Technological Controls

 

GLOBAL AI POWERED CANCER DIAGNOSTIC MARKET SIZE AND FORECAST

 

The Global AI Powered Cancer Diagnostic Market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2027, registering a CAGR of XX% from 2022 to 2027.

 

COMPETITIVE LANDSCAPE

 

Scientists are discovering new methods to use artificial intelligence (AI) in the healthcare area as it keeps expanding. AI has played a key role in the diagnosis, decision-making, and treatment of chronic diseases, particularly in medical research.

 

AI integration in precision medicine might enhance diagnostic efficiency and accuracy, help healthcare decision, and result in improved healthcare outcomes. Clinical care driven by AI has the potential to significantly reduce health inequities, especially in the low environments.

 

GE Healthcare a leading mobiliser of the Mobility solutions involving cancer solutions orienting towards AI Cancer requirements in the market. It detects and assesses the likelihood of malignancy in a lung nodule, which is crucial for assessing whether or not a biopsy is required and for speeding up diagnosis.

 

It’s the first AI-assisted diagnostic programme approved by the FDA for early-stage lung cancer, and it’s been demonstrated to enhance the high sensitivity of undetermined nodular aggressiveness evaluations.

 

Siemens AG is part of the component manufacture trending companies in the current industry. Its latest addition has been brought in through the AI-Pathway Companion Lung Cancer aids multidimensional teams (MDT) by centralising patient care and case reviews on an unified platform, offering data quality assurance, and allowing for the production of clinically important patient-specific footnotes. This is a waste of time and effort for all MDT participants.

 

COMPANIES PROFILED

• General Electric (GE) Co.
• Siemens AG
• Aidoc Medical Ltd.
• AliveCor, Inc.
• Imagen Technologies, Inc.
• VUNO, Inc.
• IDx Technologies, Inc.
• NovaSignal Corporation
• Riverain Technologies, LLC
• Zebra Medical Vision Ltd.
• Abbott
• Hoffmann-La Roche Ltd
• Becton Dickinson & Company
• Illumina, Inc.
• Koninklijke Philips N.V.

 

THIS REPORT WILL ANSWER FOLLOWING QUESTIONS

1. What is the average selling price in the Global AI Powered Cancer Diagnostic Market right now and how will it change in the next 5-6 years? 
2. Market share of Global AI Powered Cancer Diagnostic Market manufacturers and their upcoming products
3. Cost advantage for OEMs who manufacture Global AI Powered Cancer Diagnostic Market in-house.
4. 5 key predictions for next 5 years in Global AI Powered Cancer Diagnostic Market
5. Latest trends in Global AI Powered Cancer Diagnostic Market, by every market segment
6. The market size (both volume and value) of Global AI Powered Cancer Diagnostic Market in 2022-2027 and every year in between
7. Global production breakup of Global AI Powered Cancer Diagnostic Market, by suppliers and their OEM relationship
8. What is happening overall in the Global AI Powered Cancer Diagnostic Market.
9. Who are the major players in the Global AI Powered Cancer Diagnostic Market.
10. What are the business opportunities in the Global AI Powered Cancer Diagnostic Market?
11. What is the target group for the Global AI Powered Cancer Diagnostic Market?
12. What are the strategies for the Global AI Powered Cancer Diagnostic Market in the next 5 years?